References
- Mayer S, Yim G, Onesti S et al. Biopsy- proven isolated sarcoid meningitis. J. Neurosurg 78,994–996 (1993).
- Agbogu B, Stern B, Sewell C et al. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch. Nemo'. 52,875–879 (1995).
- Scott T Neurosarcoidosis: Progress and clinical aspects. Neurology43,8–12 (1993).
- Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients.Acta Neural Scand 73,283–290 (1986).
- **Zajicek JP, Scolding NJ, Foster O et al Central nervous system sarcoidosis — diadnosis and management. Q I Med. 92, 103–117 (1999).
- Delaney P Neurologic Manifestations in Sarcoidosis. Ann. Intern. Med 87,336-345 (1977).
- **Vourlekis J, Sawyer R, Newman L. Sarcoidosis: developments in etiology, immunology and therapeutics. Adv. Intern. Med. 45(2), 209–257 (2000).
- McGrath D, Daniil Z, Foley P et al Epidemiology of familial sarcoidosis in the UK. Thorax 55,751–754 (2000).
- Stem B. Neurosarcoidosis. Neural Chron. 2,1–6 (1992).
- **Constantino T, Digre K, Zimmerman P Neuro-ophthalmic Complications of Sarcoidosis. Semin. Neural 20,123-137 (2000).
- Castellano-Sanchez A. Extensive leptomeningeal and intraparenchymatous spinal cord neurosarcoidosis. Southern Med. J. 93,815–881 (2000).
- *Dumas J-L, Valeyre D, Chapelon-Abric C et al. Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy. Radiology 214,411-420 (2000).
- Handler M, Johnson L, Dick A et al. Neurosarcoidosis with usual MRI findings. Neuroradiology35, 146–148 (1993).
- *Christoforidis GA, Spiclder EM, Recio MV, Mehta BM. MR of CNS sarcoidosis: Correlation of imaging features to clinical symptoms and response to treatment. Am. Neurorad 20, 655–669 (1999).
- Borucki S, Nguyen B, Ladoulis C et al Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis. Atch. New& 46 270–273 (1989).
- Oksanen V, Fyhrquist F, Somer H et al. Angiotensin-converting enzyme in cerebral fluid. Neumlogy35, 1220–1223 (1985).
- Braunwald E, Fauci AS, Isselbacher KJ et al (Eds.) Hanison's Principles of Internal Medicine. McGraw-Hill (1998).
- Reed L, Abbas S, Flecher J. Neurosarcoidosis responding to steroids. AJR146, 819–821 (1986).
- Baughman R, Winget D, Lower E. Methotrexate is steroid sparing in acute sarcoidosis: results of a double-blind, randomized trial. Sarcoidosis Vasc. Diffuse Lung Dis. 17,60-66 (2000).
- **Lower EE, Broderick JP, Brott TG, Baughman R. Diagnosis and management of neurological sarcoidosis. Arch. Intern. Med. 157,1864-1868 (1997).
- Weiner H, Mackin G, Orav E et al Intermittent cyclophoshamide pulse therapy In progressive multiple sclerosis: final report of the Northeast Co-operative Multiple Sclerosis Treatment Group. Neurology 43, 910–918 (1993).
- Boumpas D, Yamada H, Patronas N et al Pulse cyclophosphamide for severe neuropsychiatric lupus. Q. J. Med. 81, 975–984 (1991).
- Stern B, Schonfeld A, Sewell C et al. The treatment of neurosarcoidosis with cyclosporin. Arch. Neural. 49, 1065–1072 (1992)
- Bielory L,. Holland C, Gascon P et al. Uveitis, cutaneous an neurosarcoid: treatment with low-dose cyclosporin A. Transplant Proc 20, 144–148 ( 1988).
- Sharma O. Effectiveness of cloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch. Neural. 55, 1248–1254 (1998).
- Bejar J, Kerby G, Ziegler D et al. Treatment of central nervous system sarcoidosis with radiotherapy. Ann. Neural 18, 258–260 (1985).
- Kingsley D, Kendall B. CT of the adverse effects of therapeutic radiation of the central nervous system. Ajnr 2, 453–460 (1981).